Ryan Specialty Holdings, Inc.
NYSE:RYANInsurance - Specialty
-$0.59 today
- Market cap
- $5.79B
- Beta
- 0.64
- P/E (TTM)
- 34.2
- EPS (TTM)
- $1.02
- Dividend yield
- 1.44%
Volume 1.38M
Average 2.89M
RYAN EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Ryan Specialty Holdings, Inc.NYSE: RYAN
EBITDA · Q2 FY2026 · quarter ended Jun 2026
EBITDA dips below year-ago levels
Q2 FY2026 EBITDA of $255.9M fell 4.7% year over year, behind the +7.7% change in trailing-twelve-month EBITDA. Sequentially, it rose 50.3% from the prior quarter. Over 3 fiscal years it compounded at +26.9% a year.
Context
- EBITDA amounted to 26.3% of revenue in FY2025, up 2.5 pp from a year earlier.
- EBITDA increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 12 analysts of $1.01B (+25.5%) for the fiscal year ending Dec 2026, a slowdown from the +34.2% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $255.9M+50.3% QoQ
- Last fiscal yearDec 2025
- $803.08M+34.2% YoY
- LTMJun 2026
- $789.74M+7.7% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -4.7% | +19.5% | +24.2 pp |
| 1 year | +34.2% | +25.5% | -8.6 pp |
| 3-year CAGR | +26.9% | +10.6% | -16.2 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 803.08M USD
- Year-over-year change
- +34.2%
- 4-year CAGR
- +33.4%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 803.08M | +34.2% |
| FY2024 | 2024-12-31 | 598.63M | +26.5% |
| FY2023 | 2023-12-31 | 473.27M | +20.3% |
| FY2022 | 2022-12-31 | 393.31M | +55.1% |
| FY2021 | 2021-12-31 | 253.6M | — |
EBITDA vs competitors
How RYAN compares with its peers on the latest reported figures
- RYAN's LTM Jun 2026 EBITDA of $789.74M is the 8th highest of the 9 companies compared; the peer median is $938.06M.
- Its year-over-year change of +7.7% is the 5th highest of 9, against a peer median of +7.5%.
- EBITDA amounts to 24.5% of revenue for RYAN, versus a peer median of 28.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $5.6B | +24.3% | +45.9% | 29.2% | |
| LTM Jun 2026 | $4.21B | +28.8% | — | 39.5% | |
| LTM Jun 2026 | $3.16B | +104.5% | -8.9% | 16.3% | |
| LTM Jun 2026 | $948M | -5.1% | -24.7% | 25.2% | |
| LTM Sep 2026 | $928.12M | +16.4% | +2.3% | 27.3% | |
| LTM Sep 2026 | $858.74M | -1.3% | -5.1% | 62.3% | |
| LTM Sep 2026 | $824.1M | -18.2% | +27.0% | 19.2% | |
| LTM Jun 2026 | $789.74M | +7.7% | +26.9% | 24.5% | |
| LTM Sep 2026 | $677.71M | -32.0% | -6.6% | 56.9% | |
| Peer median (excluding RYAN) | $938.06M | +7.5% | -5.1% | 28.2% | |
Competitors are the stored peer set for RYAN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.43B | 1.73B | 2.08B | 2.52B | 3.05B |
| Cost of Revenue | 0 | 0 | 0 | 0 | 287.52M |
| Gross Profit | 1.43B | 1.73B | 2.08B | 2.52B | 2.76B |
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | 90.6% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 1.13B | 1.33B | 1.6B | 1.94B | 453.45M |
| Operating Expenses | 1.37B | 1.55B | 1.84B | 2.24B | 2.14B |
| Depreciation & Amortization | 112.68M | 109.29M | 115.84M | 167.63M | 287.52M |
| EBITDA | 253.6M | 393.31M | 473.27M | 598.63M | 803.08M |
| EBITDA Margin | 17.7% | 22.8% | 22.8% | 23.8% | 26.3% |
| Operating Income | 61.56M | 179.19M | 237.93M | 272.55M | 625.23M |
| Operating Margin | 4.3% | 10.4% | 11.5% | 10.8% | 20.5% |
| Interest Income | 0 | 0 | 0 | 0 | 56.54M |
| Interest Expense | 79.35M | 104.83M | 119.51M | 158.45M | 222.38M |
| Other Income / Expenses | 0 | 0 | 0 | 0 | (332.05M) |
| Income Before Tax | 61.56M | 179.19M | 237.93M | 272.55M | 293.18M |
| Pre-Tax Margin | 4.3% | 10.4% | 11.5% | 10.8% | 9.6% |
| Income Tax Expense | 4.93M | 15.94M | 43.45M | 42.64M | 79.03M |
| Net Income | 65.87M | 61.05M | 61.04M | 94.67M | 63.4M |
| Net Margin | 4.6% | 3.5% | 2.9% | 3.8% | 2.1% |
| EPS (Basic) | (0.07) | 0.56 | 0.57 | 0.78 | 0.50 |
| EPS (Diluted) | (0.07) | 0.52 | 0.52 | 0.71 | 0.47 |
| Weighted Avg Shares | 105.73M | 108.62M | 114.36M | 120.78M | 127.27M |
| Weighted Avg Shares (Diluted) | 105.73M | 265.75M | 125.75M | 274.84M | 278.51M |
Ryan Specialty Holdings, Inc.
NYSE:RYAN
Intrinsic Alpha fair value
Locked
Current Price
$48.38
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.